Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe revision label on the page was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new build of the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision changed from v3.6.2 to v3.6.3, indicating a minor platform update. No study content or visible details were altered.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of v3.6.0. This indicates an updated release of study documents or page content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now indicates that the study is no longer recruiting participants, signaling that enrollment has closed. It also introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Interventions/Treatment header formatting, plus a revision tag update to v3.6.0.SummaryDifference0.6%

- Check58 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This is an administrative update and does not alter the study information shown to users.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3. This indicates a routine platform update that updates internal versioning rather than study information.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.